Join the 14th ACCELERATE Paediatric Strategy Forum
ACCELERATE shared a post on LinkedIn:
“Expression of interest is now open!
Join us for the 14th ACCELERATE Paediatric Strategy Forum on novel ways to target and enhance efficiency of anti-GD2 therapies.
24 and 25 October 2024. European Medicines Agency, Amsterdam and Online.
What are the goals of this Paediatric Strategy Forum?
– Identify a rational strategy to selecting specific approaches to target GD2;
– Define a roadmap for the further development of monoclonal antibodies;
– Define a roadmap to develop and evaluate new products;
– Identify and prioritise most promising new medicinal products;
– Highlight the importance of diagnostics for GD2 expression and HACA and HAHA.
Learn more and submit your expression of interest today.”
Source: ACCELERATE/LinkedIn